Following Nvidia CEO Jensen Huang’s resignation, Colette Kress will serve as interim CEO. The company says operations, customer commitments, and the product roadmap will remain consistent. Nvidia’s partnerships with life sciences companies including Eli Lilly, Thermo Fisher Scientific, and Danaher have not announced any changes. Nvidia shares fell 12.75% cumulatively over the week, closing at $162.85.
Source:Genetic Engineering & Biotechnology News · Read Original
Leave a Reply